뒤로
Mirxes Holding Company Limited(02629.HK) 가격
02629.HK 주가 차트
MIRXES-B (02629.HK)
Mirxes Holding Company Limited
HK$41.5
-7.77%
$-3.5
장 종료: Jan 16, 16:00:00 HKT
주요 통계
이전 종가
$44.46
시가
$45
일일 범위
$41.12 - $45
52주 범위
$27.05 - $77.3
거래량
450.7K
평균 거래량
748.9K
EPS(TTM)
-2.15
배당수익률
--
시가총액
$12.3B
MIRXES-B란 무엇인가요?
Mirxes Holding Co., Ltd. operates as an investment holding company. The company employs 347 full-time employees The company went IPO on 2025-05-23. The company develops and commercializes accurate, non-invasive, and affordable blood-based miRNA test kit products for the early detection of cancer and other diseases. Its segments include Infectious diseases and Early detection and precision multi-omics. Its solutions include cancer screening; clinical sequencing; cancer treatment selection, and infectious diseases. Its core product (namely, GASTROClear), two other commercialized products (namely, LUNGClear and Fortitude), and six product candidates at pre-clinical stage. GASTROClear is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. LUNGClear, its lung cancer screening product candidate, is a detection panel consisting of miRNA biomarkers discovered and verified in multi-center studies. The company offers complete COVID-19 testing solutions.